HK183395A - Method for production and purification of hepatitis b vaccine - Google Patents

Method for production and purification of hepatitis b vaccine Download PDF

Info

Publication number
HK183395A
HK183395A HK183395A HK183395A HK183395A HK 183395 A HK183395 A HK 183395A HK 183395 A HK183395 A HK 183395A HK 183395 A HK183395 A HK 183395A HK 183395 A HK183395 A HK 183395A
Authority
HK
Hong Kong
Prior art keywords
hbsag
particles
surface antigen
concentrated
hepatitis
Prior art date
Application number
HK183395A
Other languages
German (de)
English (en)
French (fr)
Inventor
Even-Chen Zeev
Original Assignee
Ferring International Center Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring International Center Sa filed Critical Ferring International Center Sa
Publication of HK183395A publication Critical patent/HK183395A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK183395A 1989-02-07 1995-11-30 Method for production and purification of hepatitis b vaccine HK183395A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30777789A 1989-02-07 1989-02-07

Publications (1)

Publication Number Publication Date
HK183395A true HK183395A (en) 1995-12-08

Family

ID=23191134

Family Applications (1)

Application Number Title Priority Date Filing Date
HK183395A HK183395A (en) 1989-02-07 1995-11-30 Method for production and purification of hepatitis b vaccine

Country Status (13)

Country Link
EP (1) EP0408742B1 (ja)
JP (1) JP2825647B2 (ja)
KR (1) KR0148119B1 (ja)
AT (1) ATE112170T1 (ja)
AU (1) AU632575B2 (ja)
CA (1) CA2026570C (ja)
DE (1) DE69012903T2 (ja)
DK (1) DK0408742T3 (ja)
ES (1) ES2061040T3 (ja)
HK (1) HK183395A (ja)
IL (1) IL93304A (ja)
RU (1) RU2080876C1 (ja)
WO (1) WO1990010058A2 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
RU2216021C2 (ru) * 1997-06-20 2003-11-10 Сиферджен Биосистемз, Инк. Способы ретентатной хроматографии для разделения аналитов в образце
RU2135209C1 (ru) * 1998-07-17 1999-08-27 Акционерное общество закрытого типа НПК "Комбиотех Лтд" Фармацевтическая композиция для иммунопрофилактики вирусного гепатита b
RU2238105C1 (ru) * 2003-03-14 2004-10-20 Закрытое акционерное общество научно-производственная компания "Комбиотех" Рекомбинантная вакцина для профилактики вирусного гепатита в (варианты)
CN103319572B (zh) * 2012-03-20 2015-06-24 北京天坛生物制品股份有限公司 一种乙型肝炎表面抗原的纯化方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442205A (en) * 1981-09-22 1984-04-10 The United States Of America As Represented By The Department Of Health And Human Services Simian virus recombinant that directs the synthesis of hepatitis B surface antigen
US4741901A (en) * 1981-12-03 1988-05-03 Genentech, Inc. Preparation of polypeptides in vertebrate cell culture
JPS6078999A (ja) * 1983-10-05 1985-05-04 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
FI861417A0 (fi) * 1985-04-15 1986-04-01 Endotronics Inc Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
US4742158A (en) * 1986-04-25 1988-05-03 Merck & Co., Inc. Purification of hepatitis pre-S antigens by polymerized serum albumin affinity binding
IL79740A0 (en) * 1986-08-17 1986-11-30 Yeda Res & Dev Hepatitis vaccine
WO1988006185A1 (en) * 1987-02-11 1988-08-25 Scripps Clinic And Research Foundation Retroviral expression vectors and methods for producing hbv antigens
US4883865A (en) * 1987-09-30 1989-11-28 Merck & Co. Inc. Recovery of pres2+s antigen
JPH0216975A (ja) * 1988-02-09 1990-01-19 Eugene Tech Internatl Inc 異成分混交性のプレーｓに富んだｂ型肝炎表面抗原

Also Published As

Publication number Publication date
AU632575B2 (en) 1993-01-07
AU5648590A (en) 1990-09-26
CA2026570A1 (en) 1991-01-08
EP0408742A1 (en) 1991-01-23
EP0408742B1 (en) 1994-09-28
CA2026570C (en) 2000-05-30
JPH03503847A (ja) 1991-08-29
WO1990010058A2 (en) 1990-09-07
EP0408742A4 (en) 1992-12-09
DE69012903T2 (de) 1995-05-11
IL93304A (en) 1992-09-06
RU2080876C1 (ru) 1997-06-10
KR910700071A (ko) 1991-03-13
WO1990010058A3 (en) 1990-11-01
KR0148119B1 (ko) 1998-08-17
IL93304A0 (en) 1990-11-29
JP2825647B2 (ja) 1998-11-18
DE69012903D1 (de) 1994-11-03
DK0408742T3 (da) 1995-03-20
ES2061040T3 (es) 1994-12-01
ATE112170T1 (de) 1994-10-15

Similar Documents

Publication Publication Date Title
KR940005588B1 (ko) 효모에서 b형 간염 바이러스 단백질을 제조하는 방법
JP2726641B2 (ja) 形質転換脊椎動物細胞の製造方法およびその細胞
EP0156242A2 (en) Lyophilized hepatitis B vaccine
US4649192A (en) Method for the isolation and purification of hepatitis B surface antigen using polysorbate
US5098704A (en) Hepatitis surface antigen particle vaccine
US4738926A (en) Method for purification of HBs antigen
JPS6136228A (ja) 肝炎表面抗原の精製方法
JPH06172393A (ja) 宿主炭水化物含量が減少したＨＢｓＡｇエスケープ変異体ワクチン
US5242812A (en) Method for production and purification of hepatitis B vaccine
EP0138167B1 (en) Method for purification of hbs antigen
EP0174444B1 (en) Hepatitis surface antigen particle vaccine
CA1066190A (en) Vaccine for active immunization containing hepatitis b surface antigen and associated antigen
EP0408742B1 (en) Method for production and purification of hepatitis b vaccine
RU2122430C1 (ru) Способ очистки поверхностного антигена вируса гепатита b, содержащего пре s2 пептид, из рекомбинантных клеток дрожжей, вакцина для иммунизации против гепатита b
US5731187A (en) Process for preparing hepatitis A (HAV) antigens and vaccines
Antoni et al. Site‐directed mutagenesis of cysteine residues of hepatitis B surface antigen Analysis of two single mutants and the double mutant
EP0511854A1 (en) Multiple hepatitis B virus surface proteins which form particles
EP0179485B1 (en) A process for the purification of hbsag
EP0328123A1 (en) Heterogeneous, pre-S rich hepatitis B surface antigen
SU728720A3 (ru) Способ получени вакцины против гепатита в
KOIKE et al. Production of hepatitis B virus surface antigen particles by the human hepatoma cell line huGK-14 in a serum-free medium
CA2078358A1 (en) Multivalent hepatitis b virus vaccine
EP0205625A1 (en) Hepatitis b virus vaccine and process for its preparation
Sitrin et al. Survey of Licensed Hepatitis B Vaccines
JPWO1986003975A1 (ja) Ｂ型肝炎ワクチン

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20100206